Bellerophon Therapeutics Inc (NASDAQ:BLPH)

4.07
Delayed Data
As of Jun 18
 -0.24 / -5.54%
Today’s Change
3.79
Today|||52-Week Range
14.09
-38.98%
Year-to-Date
Biogen (BIIB) Initiates Late-Stage Study on Lupus Candidate
Jun 18 / Zacks.com - Paid Partner Content
Arena (ARNA) Starts Phase II Study on Coronary Drug Temanogrel
Jun 09 / Zacks.com - Paid Partner Content
VBI Vaccines (VBIV) Up on Glioblastoma Drug Fast Track Status
Jun 09 / Zacks.com - Paid Partner Content